Relationship between abnormality of FHIT gene and EBV infection in gastric cancer

World Journal of Gastroenterology

Volumn 11, Issue 21, 2005, Pages 3212-3216

  Xiao, Yu Ping ^a   Han, Cheng Bo ^a   Mao, Xiao Yun ^a   Li, Jin Yi ^a   Xu, Lei ^a   Ren, Chang Shan ^a   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Fragile histidine triad; Gastric carcinoma; LOH

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EXON; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STOMACH CANCER; STOMACH CARCINOGENESIS; VIRUS DETECTION; VIRUS INFECTION; WESTERN BLOTTING; WILD TYPE;

EID: 22144484847     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i21.3212     Document Type: Article

References (30)

1. Nardone G, Rocco A, Vaira D, Staibano S, Budillon A, Tatangelo F, Sciulli MG, Perna F, Salvatore G, Di Benedetto M, De Rosa G, Patrignani P. Expression of COX-2, mPGE-synthasel, MDR-1 (P-gp), and Bcl-xL: a molecular pathway of H pylori-related gastric carcinogenesis. J Pathol 2004; 202: 305-312
2. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 1055-1062
3. Palli D. Epidemiology of gastric cancer: an evaluation of available evidence. J Gastroenterol 2000; 35: 84-89
4. Van Loon AJ, Botterweck AA, Goldbohm RA, Brants HA, van Klaveren JD, van den Brandt PA. Intake of nitrate and nitrite and the risk of gastric cancer: a prospective cohort study. Br J Cancer 1998; 78: 129-135
5. Sudo M, Chong JM, Sakuma K, Ushiku T, Uozaki H, Nagai H, Funata N, Matsumoto Y, Fukayama M. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2004; 109: 194-199
6. Van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol 2004; 22: 664-670
7. Oh ST, Seo JS, Moon UY, Kang KH, Shin DJ, Yoon SK, Kim WH, Park JG, Lee SK. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 2004; 320: 330-336
8. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma. Clin Cancer Res 2004; 10: 1698-1705
9. Mimori K, Inoue H, Shiraishi T, Matsuyama A, Mafune K, Tanaka Y, Mori M. Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus. Oncology 2003; 64: 275-279
10. Lee HS, Chang MS, Yang HK, Lee BL, Kim WH. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with Epstein-barr virus-negative carcinoma. Clin Cancer Res 2004; 10: 1698-1705
11. Han CB, Zhao YJ, Li F, He Q, Ma JM, Xin Y. Quantitation and detection of deletion in tumor mitochondrial DNA by microarray technique. Zhonghua Zhongliu Zazhi 2004; 26: 10-13
12. Fouts RL, Sandusky GE, Zhang S, Eckert GJ, Koch MO, Ulbright TM, Eble JN, Cheng L. Down-regulation of fragile histidine triad expression in prostate carcinoma. Cancer 2003; 97: 1447-1452
13. Sukosd F, Kuroda N, Beothe T, Kaur AP, Kovacs G. Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 2003; 63: 455-457
14. Baffa R, Veronese ML, Santoro R, Mandes B, Palazzo JP, Rugge M, Santoro E, Croce CM, Huebner K. Loss of FHIT expression in gastric carcinoma. Cancer Res 1998; 58: 4708-4714
15. Huiping C, Kristjansdottir S, Bergthorsson JT, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur J Cancer 2002; 38: 728-735
16. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma-associated t (3; 8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84: 587-597
17. Chang KW, Kao SY, Tzeng RJ, Liu CJ, Cheng AJ, Yang SC, Wong YK, Lin SC. Multiple molecular alterations of FHIT in betel-associated oral carcinoma. J Pathol 2002; 196: 300-306
18. An Q, Liu Y, Huang J. Comparison of tumor suppressor gene deletion between squamous cell carcinoma and adenocarcinoma lung cancer in Chinese. Zhonghua Zhongliu Zazhi 2001; 23: 470-472
19. Ko JY, Lee TC, Hsiao CF, Lin GL, Yen SH, Chen KY, Hsiung CA, Chen PJ, Hsu MM, Jou YS. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT, p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma. Cancer 2002; 94: 1987-1996
20. Wistuba II, Ashfaq R, Maitra A, Alvarez H, Riquelme E, Gazdar AF. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol 2002; 160: 2073-2079
21. Andachi H, Yashima K, Koda M, Kawaguchi K, Kitamura A, Hosoda A, Kishimoto Y, Shiota G, Ito H, Makino M, Kaibara N, Kawasaki H, Murawaki Y. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma. Br J Cancer 2002; 87: 441-445
22. Zhao P, Lu Y, Hu Y, Zhong M, Li Z, Li X. Loss of fragile histidine triad expression in colorectal carcinoma. Zhonghua Binglixue Zazhi 2002; 31: 124-127
23. Otterson GA, Xiao GH, Geradts J, Jin F, Chen WD, Niklinska W, Kaye FJ, Yeung RS. Protein expression and functional analysis of the FHIT gene in human tumor cells. J Natl Cancer Inst 1998; 90: 426-432
24. Etoh T, Kanai Y, Ushijima S, Nakagawa T, Nakanishi Y, Sasako M, Kitano S, Hirohashi S. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differeatiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol 2004; 164: 689-699
25. Kijima Y, Ishigami S, Hokita S, Koriyama C, Akiba S, Eizuru Y, Aikou T. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett 2003; 200: 33-40
26. Shibata DK. Epstein-Barr virus and gastric carcinoma. Jpn J Cancer Res 1996; 87: Inside front cover
27. Sudo M, Chong JM, Sakuma K, Ushiku T, Uozaki H, Nagai H, Funata N, Matsumoto Y, Fukayama M. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 2004; 109: 194-199
28. Zur Hausen A, Crusius JB, Murillo LS, Alizadeh BZ, Morre SA, Meijer CJ, van den Brule AJ, Pena AS. IL-1B promoter polymorphism and Epstein-Barr virus in Dutch patients with gastric carcinoma. Int J Cancer 2003; 107: 866-867
29. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004; 10: 803-821
30. Chang MS, Lee HS, Kim HS, Kim SH, Choi SI, Lee BL, Kim CW, Kim YI, Yang M, Kim WH. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. J Pathol 2003; 199: 447-452